Manshian et al., 2015 - Google Patents

High-content imaging and gene expression approaches to unravel the effect of surface functionality on cellular interactions of silver nanoparticles

Manshian et al., 2015

View PDF
Document ID
16421799982160645963
Author
Manshian B
Pfeiffer C
Pelaz B
Heimerl T
Gallego M
Moller M
del Pino P
Himmelreich U
Parak W
Soenen S
Publication year
Publication venue
Acs Nano

External Links

Snippet

The toxic effects of Ag nanoparticles (NPs) remain an issue of debate, where the respective contribution of the NPs themselves and of free Ag+ ions present in the NP stock suspensions and after intracellular NP corrosion are not fully understood. Here, we employ a recently set …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids

Similar Documents

Publication Publication Date Title
Manshian et al. High-content imaging and gene expression approaches to unravel the effect of surface functionality on cellular interactions of silver nanoparticles
Ma et al. Monitoring of the enzymatic degradation of protein corona and evaluating the accompanying cytotoxicity of nanoparticles
Selva Sharma et al. Comprehensive multispectroscopic analysis on the interaction and corona formation of human serum albumin with gold/silver alloy nanoparticles
Treuel et al. New views on cellular uptake and trafficking of manufactured nanoparticles
Li et al. Monitoring the changes of pH in lysosomes during autophagy and apoptosis by plasmon enhanced Raman imaging
Xu et al. How entanglement of different physicochemical properties complicates the prediction of in vitro and in vivo interactions of gold nanoparticles
Comfort et al. Less is more: long-term in vitro exposure to low levels of silver nanoparticles provides new insights for nanomaterial evaluation
Ali et al. Simultaneous time-dependent surface-enhanced Raman spectroscopy, metabolomics, and proteomics reveal cancer cell death mechanisms associated with gold nanorod photothermal therapy
Auchinvole et al. Monitoring intracellular redox potential changes using SERS nanosensors
Chen et al. Nanotoxicity of silver nanoparticles to red blood cells: size dependent adsorption, uptake, and hemolytic activity
Kim et al. Low dose of amino-modified nanoparticles induces cell cycle arrest
Wani et al. Nanotoxicity: dimensional and morphological concerns
Silvero C et al. Selective photoinduced antibacterial activity of amoxicillin-coated gold nanoparticles: from one-step synthesis to in vivo cytocompatibility
Suzuki et al. Simple and easy method to evaluate uptake potential of nanoparticles in mammalian cells using a flow cytometric light scatter analysis
Zhuang et al. Ratiometric fluorescence probe for monitoring hydroxyl radical in live cells based on gold nanoclusters
Wang et al. CuO nanoparticle interaction with human epithelial cells: cellular uptake, location, export, and genotoxicity
Zhang et al. Differential expression of syndecan-1 mediates cationic nanoparticle toxicity in undifferentiated versus differentiated normal human bronchial epithelial cells
Wu et al. Water-soluble dinitrosyl iron complex (DNIC): a nitric oxide vehicle triggering cancer cell death via apoptosis
Das et al. Biocompatible silver nanoparticles: An investigation into their protein binding efficacies, anti-bacterial effects and cell cytotoxicity studies
Perrin et al. Zinc and copper effects on stability of tubulin and actin networks in dendrites and spines of hippocampal neurons
Wang et al. Silver nanoparticles induce apoptosis in HepG2 cells through particle-specific effects on mitochondria
Tian et al. Gold nanoparticles biosynthesized and functionalized using a hydroxylated tetraterpenoid trigger gene expression changes and apoptosis in cancer cells
Kabiraj et al. Ellagic acid mitigates SNO-PDI induced aggregation of Parkinsonian biomarkers
Wu et al. Vacuolization in cytoplasm and cell membrane permeability enhancement triggered by micrometer-sized graphene oxide
Fan et al. Quantum dots elicit hepatotoxicity through lysosome-dependent autophagy activation and reactive oxygen species production